Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: A pooled analysis of observational data from 2547 patients

Transfusion

Volumn 54, Issue 2, 2014, Pages 289-299

  Muñoz, Manuel ^b   Gõmez Ramírez, Susana ^a   Cuenca, Jorge ^a   García Erce, José Antonio ^a   Iglesias Aparicio, Daniel ^a   Haman Alcober, Sami ^a   Ariza, Daniel ^a   Naveira, Enrique ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; CROSS INFECTION; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; OBSERVATIONAL STUDY AS TOPIC; ORTHOPEDIC PROCEDURES; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84893946405     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12195     Document Type: Article

References (49)

1. Pollard TC, Newman JE, Barlow NJ, Price JD, Willett KM,. Deep wound infection after proximal femoral fracture: consequences and costs. J Hosp Infect 2006; 63: 133-139.
2. Monge Jodra V, Sainz de los Terreros Soler L, Diaz-Agero Perez C, Saa Requejo CM, Plana Farras N,. Excess length of stay attributable to surgical site infection following hip replacement: a nested case-control study. Infect Control Hosp Epidemiol 2006; 27: 1299-1303.
3. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R,. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005; 87: 844-850.
4. Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P,. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005; 60: 93-103.
5. Shander A, Knight K, Thurer R, Adamson J, Spence R,. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116: 58S-69S.
6. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD,. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-2488.
7. Beattie WS, Karkouti K, Wijeysundera DN, Tait G,. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-581.
8. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR,. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407.
9. Izuel Rami M, García Erce JA, Gõmez-Barrera M, Cuenca Espiérrez J, Abad Sazatornil R, Rabanaque Hernández MJ,. [Relationship between allogeneic blood transfusion, iron deficiency and nosocomial infection in patients with hip fracture]. Med Clin (Barc) 2008; 131: 647-652.
10. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M,. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
11. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P,. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
12. Cuenca J, García-Erce JA, Muñoz M, Izuel M, Martínez AA, Herrera A,. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004; 44: 1447-1452.
13. Cuenca J, García-Erce JA, Martínez AA, Solano VM, Molina J, Muñoz M,. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair. Preliminary data. Arch Orthop Trauma Surg 2005; 125: 342-347.
14. García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martínez AA, Herrera A, Solano VM, Martínez F,. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 88: 235-243.
15. García-Erce JA, Cuenca J, Haman-Alcober S, Martínez AA, Herrera A, Muñoz M,. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009; 97: 260-267.
16. Cuenca J, García-Erce JA, Martínez F, Pérez-Serrano L, Herrera A, Muñoz M,. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol, reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112-1119.
17. Muñoz M, Naveira E, Seara J, Palmer JH, Cuenca J, García-Erce JA,. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Tranfus Med 2006; 16: 137-142.
18. Muñoz M, Naveira E, Seara J, Cordero J,. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 2012; 108: 532-534.
19. Haman-Alcober JS,. Aplicaciõn de un protocol de uso racional de hemoderivados en pacientes ancianos intervenidos de fractura de cadera. PhD Thesis, University of Zaragoza, Spain, 2010.
20. Iglesias-Aparicio D,. Papel del recuperador sanguíneo postoperatorio como medida de ahorro de sangre en pacientes ancianos con fractura de cuello de fémur, tratados con prõtesis de cadera. PhD Thesis. University of Zaragoza, Spain, 2011.
21. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van, Os J, Vosmaer A, van der, Ark P,. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005; 22: 249-257.
22. Garner JS, Jarvis WR, Emori TG,. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
23. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG,. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606-608.
24. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G,. Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700.
25. Dobbs RE, Parvizi J, Lewallen DG,. Perioperative morbidity and 30-day mortality after intertrochanteric hip fractures treated by internal fixation or arthroplasty. J Arthroplasty 2005; 20: 963-966.
26. Johnston P, Wynn-Jones H, Chakravarty D, Boyle A, Parker MJ,. Is perioperative blood transfusion a risk factor for mortality or infection after hip fracture? J Orthop Trauma 2006; 20: 675-679.
27. Ranhoff AH, Holvik K, Martinsen MI, Domaas K, Solheim LF,. Older hip fracture patients: three groups with different needs. BMC Geriatr 2010; 10: 65.
28. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J,; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
29. Shokoohi A, Stanworth S, Mistry D, Lamb S, Staves J, Murphy MF,. The risks of red cell transfusion for hip fracture surgery in the elderly. Vox Sang 2012; 103: 223-230.
30. Duckworth AD, Phillips SA, Stone O, Moran M, Breusch SJ, Biant LC,. Deep infection after hip fracture surgery: predictors of early mortality. Injury 2012; 43: 1182-1186.
31. Gombotz H, Rehak PH, Shander A, Hofmann A,. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468-1480.
32. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL,; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-469.
33. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB,. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81A: 2-10.
34. Llevelyn CA, Taylor RS, Todd AAM, Stevens W, Murphy MF, Williamson LM,; Leucodepletion Study Group. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 2004; 44: 489-500.
35. Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA,. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). Transfusion 2008; 48: 237-250.
36. Shander A, Spence RK, Adams D, Shore-Lesserson L, Walawander CA,. Timing and incidence of postoperative infections associated with blood transfusion: analysis of 1489 orthopedic and cardiac surgery patients. Surg Infect (Larchmt) 2009; 10: 277-283.
37. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, Rao SV, Roback JD, Shander A, Tobian AA, Weinstein R, Swinton McLaughlin LG, Djulbegovic B,; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157: 49-58.
38. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M,. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107: 477-478.
39. Kateros K, Sakellariou VI, Sofianos IP, Papagelopoulos PJ,. Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. J Crit Care 2010; 25: 348-353.
40. Serrano-Trenas JA, Font-Ugalde P, Muñoz-Cabello L, Castro-Chofles L, Rodríguez-Fernández PJ, Carpintero-Benítez P,. Role of perioperative intravenous iron therapy in elderly hip fracture patients. A single center randomized controlled trial. Transfusion 2011; 51: 97-104.
41. Na HY, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH,. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficiency patients undergoing bilateral total knee replacement arthroplasty. Tranfusion 2011; 51: 118-124.
42. Muñoz M, García-Erce JA, Remacha AF,. Disorders of iron metabolism. Part I: molecular basis of iron homoeostasis. J Clin Pathol 2011; 64: 281-286.
43. Drakesmith H, Prentice AM,. Hepcidin and the iron-infection axis. Science 2012; 338: 768-772.
44. Bellamy MC, Gednaey JA,. Unrecognised iron deficiency in critical illness. Lancet 1998; 352: 1903.
45. Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, Silvestri L,. Low hepcidin accounts for the proinflammatory ststus associated with iron deficiency. Blood 2011; 118: 736-746.
46. Muñoz M, García-Erce JA, Remacha ÁF,. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 2011; 64: 287-296.
47. Muñoz M, Martín-Montañez E,. Ferric carboxymaltose for the treatment of iron-deficiency anemia. Expert Opin Pharmacother 2012; 13: 907-921.
48. Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K,. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 2008; 52: 727-736.
49. Fleiss JL,. Determining sample sizes needed to detect a difference between two proportions. In:, Fleiss JL, Lewin B, Chopaile M, editors. Statistical methods for rates and proportions. 2nd ed. New York: Wiley; 1981. p. 38-45.